Overview
Evidence-based recommendations on faecal calprotectin tests for distinguishing between inflammatory bowel diseases (such as Crohn’s disease and ulcerative colitis) and non-inflammatory bowel diseases (such as irritable bowel syndrome).
Last reviewed: 3 May 2017
We reviewed the evidence and found nothing new that affects the recommendations in this guidance. See the review decision for more details.
Diagnostics guidance 11 has been migrated to HealthTech guidance 320. The recommendations and accompanying content remain unchanged.
Next review: This guidance will be reviewed if there is new evidence that is likely to change the recommendations.